ClotCare: Blood Clots, Stroke, Heart Attack
Monday, May 29, 2017
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

Opportunity to Host AC Forum Grand Rounds Program

Posted July, 2012

Respond by July 15, 2012

Boston University School of Medicine Continuing Medical Education, in partnership with the Anticoagulation Forum, is sponsoring a nationwide series of grand rounds meetings for community hospitals on preventing stroke in patients with atrial fibrillation with anticoagulation therapy.

These one-hour educational sessions will include a nationally renowned speaker, who will provide an interactive presentation at your site on the most current methods of anticoagulation treatment. The program will include a 45-minute didactic lecture and case-based examples. A 15-minute question and answer period will be included at the end of the lecture. In addition, the expert speaker may be able to consult on specific issues for one hour after the program.

We are offering this program to AC Forum members first. If you would like one of our speakers to present at your hospital's Grand Rounds program, please contact Michael Burk at mikeburk@bu.edu or call 617-638-6499.

Activity Type: Grand Rounds meetings in community based hospitals nationwide

Title: Preventing atrial fibrillation related strokes with anticoagulants

Course Director: David Garcia, MD

Date Range: September 1, 2012 through June 1, 2013

Accreditation: CME, CNE and CPE

Pricing: Grant funding allows for this program to be provided free-of-charge

Target Audience: Primary care providers, cardiologists, specialists in internal medicine, hospitalists, nurses, nurse practitioners, physician assistants and pharmacists

Program Goal: To inform participants about current treatment and best practices in the use of anticoagulation therapy for preventing stroke in patients with atrial fibrillation(AF) and how to implement new therapeutic treatment options, current guidelines, and best practices.

Funding Support: This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Bristol-Myers Squibb and Pfizer Inc.

Planning Committee:
David Garcia, MD, Course Director
Mark Crowther, MD
Janet Delaney, ARNP, Nurse Planner
Alan Jacobson, MD
Scott Kaatz, DO

Learning Objectives:
At the conclusion of this CME/CNE activity, participants will be able to:

  • Recognize and articulate the increased risk of stroke in patients with atrial fibrillation who receive inadequate prophylaxis
  • List both the benefits and risks of anticoagulation therapy
  • Identify strategies to utilize clinical guidelines in patient care to optimize outcomes of anticoagulation therapy
  • Discuss data related to new oral anticoagulants which might be used for preventing stroke in patients with atrial fibrillation
  • Compare warfarin to new oral agents with regards to cost, convenience, safety, efficacy, and pharmacology
  • Demonstrate increased knowledge of current clinical and pharmacoeconomic research regarding care of patients with atrial fibrillation
  • Develop strategies to improve the accuracy, frequency, and facility of communication with patients and caregivers regarding the benefits and risks of anticoagulation therapy

Accreditation Information
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Boston University School of Medicine and Anticoagulation Forum. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

To schedule an activity please contact Michael Burk at mikeburk@bu.edu or call 617-638-6499.

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

An Update on Testosterone Supplementation and Venous Thrombosis by Charles J. Glueck, M.D.

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2014 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-495-4335
Send comments to webmaster@clotcare.org.
Monday, May 29, 2017